China-based Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
Iovance Biotherapeutics, Inc., a US-based biotechnology company focused on innovating, developing, and delivering novel ...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
The Ministry of Food and Drug Safety (MFDS) in South Korea has established the "Medical Product Approval and Review...
M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a gl...
A delegation of over 20 global pharmaceutical leaders from top American, Japanese and European biopharmaceutical compani...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its suite of Thermo Scientific™ O...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologic...
The University of Melbourne and radiopharmaceutical manufacturer Cyclotek have opened the Laboratory for Advanced R...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
Japan-based Meiji Seika Pharma Co. has committed to invest in the Global Health Security Fund (GHSF), which is sponsored...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
Artificial intelligence (AI) has reshaped drug discovery, diagnostics, and genomics. The nutraceutical sector has been s...
